Bruno Gattaz
No más puestos en curso
Origen de la red de primer grado Bruno Gattaz.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
University of Grenoble
4
| College/University | Other Consumer Services | 4 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Bruno Gattaz a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| STMICROELECTRONICS N.V. | Semiconductors | Corporate Officer/Principal | |
| University of Nebraska | College/University | Masters Business Admin | |
Cantex Pharmaceuticals, Inc.
 Cantex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cantex Pharmaceuticals, Inc. develops heparin to ameliorate cardiac ischemia-reperfusion injuries. It also develops medications to enhance the safety and effectiveness of existing cancer treatments. The firm provides Disulfiram + copper Chelate that includes non-overlapping cancer stem cell killing mechanisms of actions. The company was founded in 2013 by Thomas P. Kennedy, Neil William Flanzraich and Stephen G. Marcus and is headquartered in Weston, FL. | Pharmaceuticals: Major | President | |
ST-Ericsson SA
 ST-Ericsson SA Specialty TelecommunicationsCommunications ST-Ericsson designs, develops and creates mobile platforms and wireless semiconductors. The firm supplies products and technologies to handset manufacturers. The company was founded on February 2, 2009 and is headquartered in Plan-les-Ouates, Switzerland. | Specialty Telecommunications | Chief Operating Officer | |
| RENOVARO INC. | Biotechnology | Chief Executive Officer | |
| BIOHEMP INTERNATIONAL, INC. | Pharmaceuticals: Major | Director/Board Member | |
TNG Pharmaceuticals, Inc.
 TNG Pharmaceuticals, Inc. BiotechnologyHealth Technology TNG Pharmaceuticals, Inc. engages in the development of a vaccine that reduces the horn fly population. Its vaccine counteracts the horn fly's anti-clotting agent, Thrombostasin, by triggering an immune response that clots the blood at the point of the wound. The company was founded by Larry Horn and Jennifer Corbin in 2011 and is headquartered in Louisville, KY. | Biotechnology | Chief Executive Officer | |
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin | |
SEAF Management LLC
 SEAF Management LLC Investment ManagersFinance SEAF Management LLC (SEAF) is a private equity firm founded in 1989 by Bert Jan van der Vaart. The firm is headquartered in Washington, District of Columbia. | Investment Managers | Director/Board Member | |
| Fletcher School of Law | College/University | Doctorate Degree | |
Potomac River Capital LLC
 Potomac River Capital LLC Investment ManagersFinance Potomac River Capital LLC provides investment services. The company was founded by Mark Spindel and is headquartered in Washington, DC. | Investment Managers | Corporate Officer/Principal | |
| Institut Supérieur des Affaires | College/University | Masters Business Admin | |
Arcanatura LLC
 Arcanatura LLC Agricultural Commodities/MillingProcess Industries Arcanatura LLC develops clinical trial tested health product. Its products include omega-3 supplement, resolution-3, scratches less and liver support detox. The company was founded by Serge Martinod and Xavier Fargetton in 2008 and is headquartered in Groton, CT. | Agricultural Commodities/Milling | Founder | |
Renovaro Biosciences Denmark ApS
 Renovaro Biosciences Denmark ApS Miscellaneous Commercial ServicesCommercial Services Dandrit Biotech A/S conducts clinical research, trading, and manufacturing for the pharmaceutical industry. It focuses on research and development of medicines. The company was founded on April 1, 2001 and is headquartered in Hørsholm, Denmark. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Kellogg School of Management | College/University | Masters Business Admin | |
| Dandrit Corp. Pte Ltd. | Chief Executive Officer | ||
| Novicol International Holding, Inc. | Director/Board Member | ||
Immunethep SA
 Immunethep SA BiotechnologyHealth Technology Immunethep SA develops biological products. It specializes in anti-bacterial immunotherapies based on the discovery of a virulence mechanism shared by different bacteria that cause life-threatening infections. The company was founded by Pedro Madureira and Bruno Santos and is headquartered in Cantanhede, Portugal. | Biotechnology | Director/Board Member | |
| OSE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
Skyline Vet Pharma, Inc.
 Skyline Vet Pharma, Inc. Pharmaceuticals: MajorHealth Technology Skyline Vet Pharma, Inc. engages in the manufacture of veterinary pharmaceutical products. The company was founded by Serge R. Martinod and George F. Murphy and is headquartered in Groton, CT. | Pharmaceuticals: Major | Founder | |
| Harvard Aids Initiative | Corporate Officer/Principal | ||
PharmAbbie, Inc.
 PharmAbbie, Inc. Pharmaceuticals: MajorHealth Technology PharmAbbie, Inc. manufactures pharmaceuticals. The private company is based in Groton, CT. The CEO of the company is Serge R. Martinod. | Pharmaceuticals: Major | Chief Executive Officer | |
Inhatarget Therapeutics
 Inhatarget Therapeutics Pharmaceuticals: MajorHealth Technology Inhatarget Therapeutics is a Belgian company that is developing targeted inhalation formulations to improve treatment for severe respiratory diseases, with a first focus on lung cancer. The company is based in Brussels, Belgium. The company is currently conducting clinical trials in 5 hospitals. The company's main objective is to create an inhaled chemotherapy for the treatment of lung cancer. | Pharmaceuticals: Major | Director/Board Member | |
| GENFLOW BIOSCIENCES PLC | Biotechnology | Founder | |
| Bsim Therapeutics Ltd. | Director/Board Member | ||
| PHAXIAM THERAPEUTICS S.A. | Pharmaceuticals: Major | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 19 |
| Francia | 6 |
| Canadá | 4 |
| Reino Unido | 3 |
| Dinamarca | 3 |
Sectorial
| Health Technology | 20 |
| Consumer Services | 6 |
| Finance | 4 |
| Electronic Technology | 2 |
| Retail Trade | 2 |
Operativa
| Director/Board Member | 20 |
| Chief Executive Officer | 12 |
| Corporate Officer/Principal | 8 |
| President | 7 |
| Masters Business Admin | 4 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Bruno Gattaz
- Conexiones Empresas
